The company was SGD (Pink Sheets: SGDH) . There could have been funding issues on SGDs side. We don't know for sure. You can go back a year and check the SGDH board for more information on that. Metiscan wasn't making any money so they may have been on a search as what to do to fix things. Personally, I think Aclor saw the merger as a great way to grow the company. Good numbers will give Aclor a way to raise capital, pay down debt and grow the business. Time will tell.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.